[Clinico-pharmacological and clinical evaluation of pengitoxin].
作者信息
Haustein K O, Wesser M
出版信息
Farmakol Toksikol. 1982 May-Jun;45(3):67-8.
PMID:7095131
Abstract
摘要
相似文献
1
[Clinico-pharmacological and clinical evaluation of pengitoxin].
Farmakol Toksikol. 1982 May-Jun;45(3):67-8.
2
[Preliminary study of the bioavailability of digoxin, desacetyllanatoside C and of acetyl-digoxin in oral administration].
Boll Soc Ital Cardiol. 1977;22(7):1064-72.
3
On the pharmacokinetics of 16-acetyl-gitoxin and its bioavailability from pengitoxin-containing tablet formulations.
J Pharmacokinet Biopharm. 1986 Aug;14(4):357-64. doi: 10.1007/BF01059196.
4
[No advantages of acetyldigoxin and methyldigoxin compared to digoxin].
Dtsch Med Wochenschr. 1982 May 28;107(21):831-3. doi: 10.1055/s-2008-1070029.
5
On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl-gitoxin.
Eur J Clin Pharmacol. 1983;25(3):369-73. doi: 10.1007/BF01037950.
6
[Therapeutic comparison between digoxin, beta-methyl-digoxin and beta-acetyl-digoxin].
Clin Ter. 1981 Nov 15;99(3):281-93.
7
[Controlled clinical study on beta-acetyldigoxin].
Clin Ter. 1984 Aug 15;110(3):243-9.
8
Differences in color vision impairment caused by digoxin, digitoxin, or pengitoxin.
J Cardiovasc Pharmacol. 1982 Jul-Aug;4(4):536-41. doi: 10.1097/00005344-198207000-00003.
9
[Digoxin, derivatives and digitoxin: standardized comparison pharmacokinetics].
Verh Dtsch Ges Kreislaufforsch. 1977;43:425.
10
[Improvement of cardiac glycoside therapy].
Z Gesamte Inn Med. 1979 Jun 15;34(12):337-8.
引用本文的文献
1
On the pharmacokinetics of 16-acetyl-gitoxin and its bioavailability from pengitoxin-containing tablet formulations.
J Pharmacokinet Biopharm. 1986 Aug;14(4):357-64. doi: 10.1007/BF01059196.
Zotero 插件